Sutro Biopharma Inc. Company Profile
NASDAQ: STROHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
14.66+0.21 (+1.45%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Sutro Biopharma at a glance
Sutro Biopharma Inc. (NASDAQ: STRO) is a Biotechnology: Biological Products (No Diagnostic Substances) company in the Health Care sector. The company's shares have traded publicly since 2018. At a market capitalization of $239.6 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001382101, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
Company information
- Legal name
- Sutro Biopharma Inc.
- Ticker
- NASDAQ: STRO
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Headquarters
- United States
- IPO year
- 2018
- Market cap
- $239.60M
- SEC CIK
- 0001382101
Companies similar to Sutro Biopharma
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| LCTXLineage Cell Therapeutics Inc. | 0.9476 | +1.03% | $239.66M | vs STRO |
| IPSCCentury Therapeutics Inc. | 1.28 | -3.03% | $231.78M | vs STRO |
| FATEFate Therapeutics Inc. | 2.15 | -6.11% | $257.61M | vs STRO |
| PALIPalisade Bio Inc. | 1.48 | -0.67% | $257.92M | vs STRO |
| PLXProtalix BioTherapeutics Inc. (DE) | 2.71 | -0.73% | $218.35M | vs STRO |
| SABSSAB Biotherapeutics Inc. | 2.88 | -1.71% | $262.04M | vs STRO |
| IVVDInvivyd Inc. | 0.7286 | -9.65% | $214.76M | vs STRO |
| ALECAlector Inc. | 1.92 | +6.08% | $214.38M | vs STRO |